This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Philip Marsden is a panelist during the session titled “Excessive prices in pharmaceutical markets.”
For more information on this event, click here.
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...
Their recommendations include: Using simultaneous vGUPPIs to account for feedback effects between raising rivals’ costs (RRC) incentives and elimination of...
The Annual CRA Brussels Conference, to be held exclusively at the Steigenberger Wiltcher’s Hotel on Tuesday, 9 December 2025, will focus on the pursuit of...
Yajing Jiang moderates the latest Groundbreakers seminar, featuring Leon Musolff’s paper (co-authored with Kwok-Hao Lee), “Two-Sided Markets and...
